Propanc Biopharma (PPCB) Enterprise Value Growth (3y) (2018 - 2025)
Propanc Biopharma (PPCB) Enterprise Value Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -214.39% |
| Jun 30, 2025 | -43.78% |
| Dec 31, 2024 | 41.64% |
| Sep 30, 2024 | 41.30% |
| Jun 30, 2024 | -110.67% |
| Mar 31, 2024 | 24.47% |
| Dec 31, 2023 | -49.97% |
| Mar 31, 2023 | -51.23% |
| Dec 31, 2022 | -26.74% |
| Sep 30, 2022 | 41.35% |
| Jun 30, 2022 | -19.32% |
| Dec 31, 2021 | 16.08% |
| Sep 30, 2021 | -5.59% |
| Jun 30, 2021 | 51.63% |
| Mar 31, 2021 | -15.81% |
| Dec 31, 2020 | 42.63% |
| Mar 31, 2020 | -43.84% |
| Dec 31, 2019 | 34.57% |
| Sep 30, 2019 | -56.84% |
| Jun 30, 2019 | 72.96% |